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Abstract
Tungiasis (sand flea disease) is a neglected tropical disease, prevalent in resource-poor communities in South America and
sub-Saharan Africa. It is caused by an inflammatory response against penetrated female sand fleas (Tunga penetrans)
embedded in the skin of the host. Although associated with debilitating acute and chronic morbidity, there is no proven
effective drug treatment. By consequence patients attempt to remove embedded sand fleas with non-sterile sharp
instruments, such as safety pins, a procedure that represents a health threat by itself. In this proof-of-principle study we
compared the topical application of a mixture of two dimeticones of low viscosity (NYDA) to the topical application of a
0.05% solution of KMnO4 in 47 school children in an endemic area in rural Kenya. The efficacy of the treatment was assessed
during a follow up period of seven days using viability signs of the embedded parasites, alterations in the natural
development of lesion morphology and the degree of local inflammation as outcome measures. Seven days after treatment,
in the dimeticone group 78% (95% CI 67–86%) of the parasites had lost all signs of viability as compared to 39% (95% CI 28–
52%) in the KMnO4 group (p,0.001). In the dimeticone group 90% (95% CI 80–95%) of the penetrated sand fleas showed
an abnormal development already after 5 days, compared to 53% (95% CI 40–66%; p,0.001) in the KMnO4 group. Seven
days after treatment, signs of local skin inflammation had significantly decreased in the dimeticone group (p,0.001). This
study identified the topical application of dimeticones of low viscosity (NYDA) as an effective means to kill embedded sand
fleas. In view of the efficacy and safety of the topical treatment with dimeticone, the mechanical extraction of embedded
sand fleas using hazardous instruments is no longer warranted.
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Introduction
Tungiasis (sand flea disease) is a neglected tropical disease
frequent in South America, The Caribbean and in sub-Saharan
Africa. [1,2,3]. It is prevalent in resource-poor rural and urban
communities, where animal reservoirs are present and people live
in poverty [2,4,5,6,7,8]. In the last decade, tungiasis has re-
emerged in East Africa in epidemic dimensions [9]. In 2010,
Ahadi Kenya Trust, a non-governmental organization, reported
several hundred thousand cases of tungiasis in Kenya alone, of
which the majority were children [4,10,11].
Sand flea disease is the result of an intense inflammatory
response against penetrated sand fleas embedded in the skin of the
host. The mechanisms underlying the inflammation are complex
and only partially understood [11,12,13]. Immediately after a
successful penetration the female sand flea starts to hypertrophy
reaching the size of a pea after 10 days [14]. Through its
abdominal rear cone the parasite remains in contact with the
environment [14]. The tiny opening in the skin (250 to 500 mm) is
needed for copulation with male sand fleas, breathing, defecation
and expelling eggs [14]. After expulsion of all eggs the female sand
flea dies in situ and is discarded from the epidermis by tissue repair
mechanisms [14].
Although by its nature a self-limiting infection, tungiasis is
actually a debilitating disease in endemic areas [15]. Sequels are
common and are related to repeated and severe infection. They
include acute and chronic inflammation of toes, deformation and
loss of toe nails, fissures and lymphoedema [11].
Bacterial super-infection is almost invariably present [13]. It
increases the inflammation and leads to intense pain [16]. If
embedded sand fleas are removed by using inappropriate sharp
instruments, severe mutilation of the feet may develop including
deep ulcers, gangrene and loss of toes [15]. Septicaemia has also
been described [17] and tetanus is a known deadly sequel in non-
vaccinated individuals [18].
Hitherto, the only effective treatment is the surgical extraction
of embedded sand fleas under sterile conditions in medical
facilities. However, in the endemic areas patients do not have
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access to appropriately equipped health centers and therefore use
any kind of sharp instruments (safety pins, sewing needles, hair
pins, sharpened pieces of wood, etc.) to remove embedded sand
fleas. Attempts to remove the embedded parasites by using a sharp
instrument, invariably causes a (micro) hemorrhage [9]. As the
same instrument is frequently used to remove embedded sand fleas
from different persons, this procedure increases the risk of the
transmission of blood-borne pathogens, such as hepatitis B and C
virus [19].
In an act of desperation, patients may apply toxic substances to
the skin with the intention of killing the embedded parasites. In
Brazil and Madagascar, for instance, kerosene, used petrol, and
insecticides are used [9,20]. In rural Uganda, a crop pesticide used
in tomato cultivation is applied (H. Feldmeier, unpublished
observation 2013).
In the absence of safe and effective treatment options, Ahadi
Kenya Trust recommends to bath the feet in a 0.05% solution of
potassium permanganate (KMnO4) for 10 minutes [10]. Howev-
er, the efficacy of this approach is not known. In Brazil several
antihelminthic compounds, including ivermectin, have been
tested, but none proved to be a really effective [21].
Dimeticones are silicone oils of low viscosity with a low surface
tension and excellent creeping properties. They are highly effective
against head lice [22]. The substance creeps into the tracheae of
head lice and leads to lethal asphyxia within one minute [23]. The
mode of action is purely physical. Dimeticones are biochemically
inert and are not absorbed when applied to the skin or swallowed
[24]. They are neither carcinogenic nor teratogenic and are
considered wholly non-toxic [24].
Previous observation in rats infested with T. penetrans showed
that if a drop of a solution of two dimeticones of low viscosity
(NYDA) was applied on top of the protruding rear cone of an
embedded sand flea, the parasite rapidly lost signs of viability (H.
Feldmeier, unpublished observation 2011). Based on this obser-
vation we decided to investigate the efficacy of the dimeticone for
the treatment of tungiasis in a proof-of-principle study in rural
Kenya. The results show that wetting the skin of the feet with
dimeticones with low viscosity effectively kills embedded sand fleas
and reduces tungiasis-associated inflammation within seven days.
Materials and Methods
Study area and study population
The study was performed in Gatundu North District, central
Kenya, approximately one hour north of Nairobi. Tungiasis is
endemic in this region. People live in small hamlets in houses
made of wood or bricks. Families earn their living from subsistence
farming. Most households possess animals, dogs, chicken and pigs.
The animals live on the compound or are brought back to it in the
night. Living conditions are generally very poor.
The study participants were school children aged five to sixteen
years enrolled at the public Kiamwangi Primary School and
Ikuma Primary School, which are situated five km to each other.
The classrooms consist of simple houses without a solid floor. Both
schools have a limited access to water, so that the schoolyards and
rooms cannot be cleaned regularly. Most pupils wore worn-out
sandals or walked barefoot. The study was carried out between
January 10 and February 17, 2012. This period coincides with the
high transmission period of T. penetrans.
Study design
To allow comparison between the new approach (the applica-
tion of the dimeticone) and the local reference procedure (bathing
feet in a 0.05% solution of KMnO4), one foot was bathed in the
KMnO4 solution for 10 minutes and to the other foot the
dimeticone was applied three times during this period (see below).
Since bathing a foot in a 0.05% KMnO4 solution changes the
color of the skin into dark purple, neither the patient nor the
examiner were blinded with regard to the treatment applied.
Individuals, aged$5 years, with at least one lesion in stage IIa –
IIIa of the Fortaleza classification on each foot were eligible [14].
In IIa the sand flea is already completely embedded in the skin of
the host and has started to hypertrophy [14]. Lesions in stage IIIa
correspond to a fully developed parasite with a characteristic
watchglass-like appearance. In this stage the female sand flea starts
to expel eggs [14]. In stage IIIb egg expulsion stops, thereafter the
sand flea dies and the lesion changes into stage IV: the lesion
becomes crusted, viability signs become rare and eventually
completely disappear [14]. Hence, sand fleas in stage IIa – IIIa are
most suitable to assess viability and alterations in the normal
development of the parasites.
The inclusion criterion for an eligible lesion was the presence of
at least 2 out of 4 viability signs at the baseline examination:
expulsion of eggs, excretion of a faecal thread, excretion of faecal
liquid or pulsations/contractions of the parasite. Viability signs
were determined using a handheld digital video microscope
(eScope iTEZ, Hongkong, China) (see supplementary electronic
material 1).
When several eligible lesions were present on one foot only
those (at most three) were selected for evaluation that allowed a
clear discernment of the developmental stage of the embedded
parasite and a quantification of the inflammatory response around
the lesion. Hence, lesions occurring in cluster and lesions which
the patient had attempted to manipulate were excluded. Other
exclusion criteria were: Presence of gross inflammation, abscess or
ascending lymphangitis or lymphedema on either foot. Children
with such complications of tungiasis were referred to the nearest
health facility for treatment.
For practical reasons we decided to treat always the same foot
with dimeticone and KMnO4, respectively. At the beginning of
the study a coin was tossed for randomizing the two treatments.
Author Summary
Tungiasis (sand flea disease), a parasitic skin disease,
causes important morbidity, and eventually leads to
mutilation of the feet. Hitherto, the only effective
treatment is the surgical extraction of embedded sand
fleas. In the endemic areas this is done using inappropriate
sharp instruments and causes more harm than good. We
identified the three last abdominal segments of Tunga
penetrans which protrude through the skin and through
which the parasite breathes, defecates, and expels eggs -
as an Achilles heel of embedded sand fleas. In a proof-of-
principle study we investigated whether this Achilles heel
is vulnerable to dimeticone with a low viscosity and a high
creeping property. We randomized the left and the right
feet to either receive a topical application of KMnO4 (the
standard treatment in Kenya) or of dimeticone. The major
outcome measure was the absence of viability signs of the
treated sand fleas. The study shows that the topical
application of a mixture of two dimeticones (NYDA)
effectively kills embedded sand fleas within seven days.
Since dimeticones are considered to be wholly non-toxic
and are not expensive the new treatment could become a
means to control tungiasis-associated morbidity on the
population level.
Treatment of Tungiasis with Dimeticone
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This resulted in application of the dimeticone to the left foot and of
KMnO4 to the right foot. Children were informed not to
manipulate the lesions during the next seven days.
Before each examination the feet of the participants were washed
properly with water and soap and dried with a clean towel. Then, the
left foot was wetted with NYDA up to the ankle three times within
Figure 1. Flow diagram.
doi:10.1371/journal.pntd.0003058.g001
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10 minutes. In the interval, the foot was kept in an upright position
to allow surplus dimeticone to evaporate. Simultaneously, the right
foot was put into a bucket containing a 0.05%KMnO4 solution, and
remained there for 10 minutes. After sun drying the right foot,
vaseline was applied to compensate the desiccation of the skin caused
by KMnO4. The immersion of the foot in 0.05% KMnO4 for
10 minutes and the subsequent oiling with vaseline is the standard
procedure applied by Ahadi Kenya Trust. After treatment the
children were allowed to continue their daily activities.
The lesions were monitored daily for viability signs and the
abnormal development of the embedded parasite for a total of
seven days. One week reflects the period of normal development of
a sand flea from stage IIa to stage IIIa [14]. Thereafter, it looses its
characteristic watchglass-like appearance, but does not increase in
size anymore [14]. Hence, abnormalities in development are
difficult to be detected.
In order to detect a change of tungiasis-associated inflammation
an inflammation score was developed. In addition to the classic
signs of local inflammation (erythema, oedema and warmness) the
score included the presence of suppuration, ulcers and fissures as
well as itching and pain. The inflammation score ranged from 0 to
27 points [25].
In total, 48 participants were recruited and 47 were random-
ized. The flow diagram is shown in Figure 1.
Table 1. Demographic and clinical data of study participants at baseline.
Treatment applied
Variable NYDA (left foot) KMnO4 (right foot)
Median number of lesions on respective foot (range)a 25 (8–112) 25 (6–107)
Median of viable lesions (range)b 3 (1–29) 2 (1–25)
Median of non-viable lesions (range)c 3 (0–30) 2 (0–36)
Median of manipulated lesions (range)d 18 (6–53) 18 (4–54)
Number of viable lesions included in the studye: 88 82
stage IIa 52 51
stage IIb 35 31
stage IIIa 1 0
atotal number of viable, non-viable and manipulated sand flea lesions.
bsand flea lesions in stage I to IIIb, according to the Fortaleza Classification.
clesions in stage IV and V, according to the Fortaleza Classification.
dlesions manipulated with a sharp instrument by the patient himself or a caregiver.
emaximum of 3 lesions per foot (see material and methods).
doi:10.1371/journal.pntd.0003058.t001
Table 2. Efficacy of treatment based on viability of embedded sand fleas.
Treatment
NYDA viable/total
lesions (%) Efficacy (%)a
KMn04 viable/total
lesions (%) Efficacy (%)a p-valueb
Baseline All lesionsc 89/89 (100%) 0% 82/82 (100%) 0%
- early stages (IIa)d 52/52 (100%) 0% 52/52 (100%) 0%
- later stages (IIb–IIIa)d 37/37 (100%) 0% 30/30 (100%) 0%
Day 3 All lesionsc 27/54 (50%) 50% 43/50 (86%) 14% ,0.001
- early stages (IIa)d 12/28 (43%) 67% 29/33 (88%) 12% ,0.001
- later stages (IIb–IIIa)d 15/26 (58%) 42% 14/17 (82%) 18% 0.10
Day 5 All lesionsc 33/72 (46%) 54% 43/58 (74%) 26% 0.001
- early stages (IIa)d 18/43 (42%) 58% 26/37 (70%) 30% 0.01
- later stages (IIb–IIIa)d 15/29 (52%) 46% 17/21 (81%) 19% 0.04
Day 7 All lesionsc 19/86 (22%) 78% 43/71 (61%) 39% ,0.001
- early stages (IIa)d 6/49 (12%) 88% 27/45 (60%) 40% ,0.001
- later stages (IIb–IIIa)d 13/37 (35%) 65% 16/26 (62%) 38% 0.04
aproportion of parasites which lost all viability signs.
bdimeticone versus KMnO4 treatment.
cThe total number of lesions examined varied at follow up examinations, because some participants could not be examined at the days foreseen, especially at the
weekends (see flow diagram).
daccording to the Fortaleza classification.
doi:10.1371/journal.pntd.0003058.t002
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Outcome measures
Two major outcome measures were defined. First, the
proportion of viable embedded sand fleas which lost viability
signs after seven days of follow-up. An embedded sand flea was
considered to be dead when none of the four viability signs
(expulsion of egg, excretion of faecal thread, excretion of faecal
liquid, pulsations/contractions) was detected during 15 minutes of
observation with the digital handhold video microscope on two
consecutive follow-up examinations. Videos were recorded and
reviewed in the evening of the examination day (see supplemen-
tary electronic material 1). Second, the proportion of embedded
sand fleas in which the normal development was interrupted. We
defined a development as abnormal, when the lesion did not
change its size within two consecutive follow ups and/or
Table 3. Efficacy of treatment based on the morphological development of sand flea lesions.
Treatment applied
NYDA KMnO4 p-valueb
Abnormal development/total lesions (%)a
Day 3 All lesionsc 41/54 (76%) 22/50 (44%) ,0.001
- early stages (IIa)d 19/28 (68%) 12/33 (36%) 0.021
- later stages (IIb–IIIa)d 22/26 (85%) 10/17 (59%) 0.080
Day 5 All lesionsc 65/72 (90%) 31/58 (53%) ,0.001
- early stages (IIa)d 40/43 (93%) 20/37 (54%) ,0.001
- later stages (IIb–IIIa)d 25/29 (86%) 11/21 (52%) 0.012
Day 7 All lesionsc 79/86 (92%) 45/71 (63%) ,0.001
- early stages (IIa)d 45/49 (92%) 27/45 (60%) ,0.001
- later stages (IIb–IIIa)d 34/37 (92%) 18/26 (69%) 0.040
asee definition in materials and methods.
bdimeticone versus KMnO4 treatment.
cThe total number of lesions examined varied at follow up examinations, because some participants could not be examined at the days foreseen, especially at the
weekends (see flow diagram).
daccording to the Fortaleza classification.
doi:10.1371/journal.pntd.0003058.t003
Figure 2. Photo series of two lesions located next to the nail rim of the fifth toe; treatment with dimeticone. (A) Baseline: Two sand flea
lesions in stage IIIa are located next to each other with the characteristic watchglass-like elevation. The abdominal cone is the circular brownish
protrusion in the center of the lesions. (B) Day 3: The abdominal cones have changed in a brownish-black crust, the watchglass-like elevations have
vanished and the lesions have dried out. Desquamation of the stratum corneum around the lesions has started. No signs of viability were detected.
(C) Day 7: The appearance of the lesions has not changed; desquamation has slightly increased.
doi:10.1371/journal.pntd.0003058.g002
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morphological abnormalities developed, e.g. discoloring or desic-
cation of the abdominal rear cone [14].
A secondary outcome measure was the intensity of local
inflammation, as assessed semi-quantitatively by the inflammation
score. The observation units for all outcome measures were single
sand flea lesions.
Statistical analysis
The sample size calculation was based on the following
assumptions: with a level of confidence set at 95% together with
a power of 90% assuming equal number of lesions in treatment
and control group, 45 lesions in each group were needed to
determine a difference of 35% in the major outcome measure
between the two treatments assuming a 40% effect of the standard
treatment.
Fisher’s exact test was used to compare proportions. General
estimation equations were used to analyze the evolution of the
inflammation score during the observation period.
Ethical considerations
The study was approved by the Ethics Committee of the
Ministry of Health, Nairobi (MMS/ADM/3/8/Vol 111), and was
registered at Controlled-trials.com (ISRCTN: 91405042). The
study was performed in accordance with the ethical standards of
the Ethics Committee of the Ministry of Health, and with the
Declaration of Helsinki as amended 2013 by the World Medical
Association. Informed written consent was obtained from the
guardians of the participants in English before starting the study.
For ethical reasons no controls were included. During the study,
food was provided free of charge to the participants. At the end of
the study, any remaining viable sand fleas were removed under
sterile conditions and the wounds were dressed following standard
procedures. All patients received a new pair of closed solid shoes.
Results
Baseline characteristics
The baseline characteristics of the feet of the 47 participants are
summarized in Table 1. None of the variables differed significantly
between the two feet. In the NYDA group, 88 lesions were
included in the study, in the KMnO4 group 82.
Major outcome measures
Table 2 shows the efficacy of treatment based on the
disappearance of viability signs. Already three days after applica-
tion of dimeticone 50% of the parasites lost all viability signs
(efficacy = 50%), whereas the efficacy in the KMnO4 group was
14% (p,0.001). At day 7 the efficacy was 78% (95% CI 67–86%)
after treatment with dimeticone and 39% (95% CI 28–52%) after
treatment with KMnO4 (p,0.001); a difference of 39% (95% CI
23–54%). In the dimeticone group, lesions in an early stage of
development lost viability signs more often than lesions in later
stages (efficacy = 88% (95% CI 75–95%) versus 65% (95% CI 47–
79%) at day 7 (p = 0.01)). In the KMnO4 group, there was no
difference between lesions in early and later stages of development.
The effect of treatment on the morphological development of
the lesions is shown in Table 3. Already after 5 days in the
dimeticone group 90% (95% CI 80–95%) of sand flea lesions
showed an abnormal development as compared to 53% (95% CI
40–66%) (p,0.001) in the KMnO4 group.
Figure 2A–C and 3A–C show the macroscopic development of
lesions after the treatment with dimeticone or KMnO4, respective-
ly. Figure 4A–D and 5A–D depict the microscopic development of
Figure 3. Photo series of a lesion located at the base of the first toe; treatment with KMnO4. (A) Baseline: A lesion in stage IIIa with a
diameter of 10 mm at the base of the first toe. The abdominal cone is the circular brownish protrusion in the center of the elevation. The dermal
papillae next to the lesion contain faecal material expelled by the parasite. (B) Day 3: The sand flea has expulsed several eggs (white oval dots). One of
the eggs is in progress of being expelled. The appearance of the lesion has not changed. (C) Day 7: The lesion has retained its size and remains
elevated. Recently excreted faecal material has spread into the dermal papillae next to the lesion, another indicator that the parasite remained viable.
doi:10.1371/journal.pntd.0003058.g003
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lesions after treatment as seen through the digital handhold video
microscope.
Inflammation score
In the dimeticone group the inflammation score decreased from
a median of 6.0 at baseline to a median of 4.75 at day 7. In
contrast, in the KMnO4 group, the inflammation score increased
(median 4.5 versus 5.0). Both differences were significant (p,
0.0001 and p= 0.009, respectively).
Ancillary findings
During the study period three sand fleas were extracted by the
participants or their caregiver in the NYDA group and 11 in the
KMnO4 group.
Discussion
Tungiasis, a wide spread neglected tropical disease, is prevalent
in resource-poor rural and urban communities, where animal
reservoirs are present and people live in poverty [2,4,5,6,7,8].
Elimination of sand flea disease is not possible as long as the
precarious living conditions, which are characteristic of the
endemic areas, prevail and animal reservoirs exist.
Taking into consideration the high prevalence of tungiasis, the
absence of appropriate infrastructure in the endemic areas and the
health hazards associated with the traditional treatment, there is
an urgent need for a safe and effective drug treatment. Recently,
dimeticones have emerged as highly effective chemicals against
ectoparasites such as head lice [26]. Since dimeticones have a
purely physical mode of action and are considered to be non-toxic,
they have become the standard treatment of pediculosis capitis in
Europe [22].
We considered the last abdominal segments of an embedded
sand flea, which protrude through the skin by forming a miniature
cone and through which the parasite breathes, defecates and
excretes eggs, as an Achilles heel, which can be targeted by
dimeticone. Since the opening leading to internal organs measures
less than 1 mm, we decided to use a combination of two
dimeticones of very low viscosity with a low surface tension and
excellent creeping properties (NYDA) [23].
We defined a set of viability signs of embedded sand fleas
detectable through a handhold digital video microscope. We used
the presence of viability signs as the major outcome measure and
compared the efficacy of a 0.05% solution of KMnO4 – the
standard treatment used in mass campaigns in Kenya – to wetting
the foot with dimeticone three times during a period of
10 minutes. The observation period was limited to seven days,
since a certain number of embedded sand fleas will die even
without any intervention during this period [14].
After 7 days, 78% of the lesions did not show any sign of
viability in the dimeticone group, whereas the proportion was 39%
in the KMnO4 group. True efficacy of a 0.05% solution of
KMnO4 alone may be lower since KMnO4 is a disinfectant and
has no insecticidal properties. It is unlikely that KMnO4 diluted in
water will creep into vital organs of embedded sand fleas through
the parasite’s abdominal cone. Presumably, the observed effect in
Figure 4. Photo series of a lesion documented by the digital handhold video microscope at 200 fold magnification; treatment with
dimeticone. (A) Baseline: Lesion in stage IIb. The abdominal cone is the circular brownish protrusion in the center. The cone is surrounded by a
slightly elevated circle. The dark area on the right is part of the toe nail. (B) Day 3: The abdominal cone has changed in a brownish crust. The stratum
corneum covering the embedded parasite has started to desquamate. No viability signs detectable. (C) Day 5: The rear cone has changed into a black
crust. The desquamation has significantly enlarged. The uncovered intersegmental skin of the abdomen of the parasite has turned into dark-purple.
(D) Day 7: The appearance of the lesion has remained similar; desiccation and desquamation have continued.
doi:10.1371/journal.pntd.0003058.g004
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the KMnO4 treated lesions was due to the vaseline which was
applied to the skin for cosmetic reasons (because bathing the feet in
KMnO4 makes the skin rough and cracked). Applied on the skin,
vaseline rapidly turns into oil, particularly in hot climate countries.
Liquid fatty acids of the vaseline may thereby creep into the
abdominal rear cone and suffocate the parasite.
Interestingly, the efficacy of dimeticone to kill embedded sand
fleas depended on the stage of development: parasites being in an
early stage of development were more susceptible than those who
had already fully developed (efficacy = 88% versus 66%). This is
plausible, since embedded sand fleas increase their size by a factor
of approximately 2000 within 6–7 days during the development
from stage IIa to stage IIIa [14]. Such a rapid growth requires an
intense metabolism, which in turn needs constant supply of
oxygen. During the early stages of development supply of oxygen
might be at a critical limit. This makes the parasite vulnerable for
suffocating compounds such as low-viscosity.
Since it is important to kill sand fleas as soon as they have
penetrated in order to prevent the development of clinical
pathology [16], the enhanced effect of dimeticone on early
developmental stages is an additional advantage. The early death
of the embedded parasite will also prevent the expulsion of eggs –
which starts about one week after penetration – and, thereby, may
have an impact on transmission.
92% of the embedded fleas treated with dimeticone showed an
abnormal development. This could indicate that no (or fewer) eggs
are produced and released into the environment. Hence, if applied
on the population level, treatment with dimeticones could have
even an impact on the off-host cycle of the parasite, possibly
resulting in lower attack rates over time.
In the dimeticone group, the inflammation score started to
decrease after 3 days and became significantly lower after 7 days,
whereas in the KMnO4 group the inflammation slightly increased.
It is conceivable that the resolution of inflammation reflects the
rapid death of the parasites. Previous studies have shown that
tungiasis-associated inflammation comes to a halt and tissue repair
mechanism begins, when the parasites are dead [25,27].
Another indicator of the efficacy of the dimeticone was that in
the course of the study 11 sand fleas were extracted from the feet
treated with KMnO4 by the patients themselves, whereas in the
NYDA treated feet only 3 sand fleas were removed. Similarly,
when the study participants were asked at the end of the study
about their satisfaction, only 10 participants preferred KMnO4,
but 37 preferred the dimeticone. Children also disliked that
KMnO4 colored the skin into deep purple for a few days which led
to teasing in school (Figure 6).
This study on the treatment of a neglected parasitic disease is
particularly in the sense that an Achilles heel of the parasite was
identified first and then a compound was identified that is able to
target the vulnerable body part. The abdominal cone which
protrudes through the skin and through which the parasite
breathes, defecates, excretes liquids and expels eggs was consid-
ered to be an ideal target for a dimeticone with a low viscosity and
excellent creeping properties.
Figure 5. Photo series of a lesion documented by the digital handhold video microscope at 200 fold magnification; treatment with
KMnO4. (A) Baseline: Lesion in stage IIIa. The abdominal cone is the circular brownish protrusion surrounded by the characteristic watchglass-like
elevation. The curved line is faecal material of the parasite that has spread into dermal papillae. (B) Day 3: The embedded parasite has grown slightly
and the convex elevation is more embossed. The abdominal cone is still brownish and shining. (C) Day 5: The appearance of the lesion has not
changed. Faecal liquid is excreted through the abdominal cone and appears as a clear, light-reflecting ‘‘pond’’ on the top of the cone. (D) Day 7: The
abdominal cone is still brownish and shining. The lesion has a convex double-rim appearance. Two viability signs (pulsation of the parasite and
excretion of liquid) were present at this moment.
doi:10.1371/journal.pntd.0003058.g005
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Figure 6. Left and right foot after the application of the dimeticone and KMnO4, respectively. The dark coloring of the right foot is due
to KMnO4. The yellow jelly on the right foot is vaseline being in the process of dissolution.
doi:10.1371/journal.pntd.0003058.g006
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Although this was a proof-of-principle study with a small
number of units of observations, it can be concluded that the
topical application of a mixture of two dimeticones (NYDA)
comprises a promising approach to treat sand flea disease. The
treatment can be performed by the patient himself with minimal
input from the health sector. Hence, surgical extraction with all its
associated complications is no longer warrantable. After the sand
flea has died in situ, the inflammation resolved. Importantly,
future resistance of the parasites against dimeticone treatment is
highly unlikely to evolve, since the drug acts only physically.
Supporting Information
Video S1 Embedded sand flea produces faecal thread. Video of
an embedded sand flea in stage IIb using a handheld digital video
microscope. The lightly brownish abdominal rear cone is
magnified 200 fold. The cone is contracting and producing a
black faecal thread. In the surrounding of the cone pulsations of
the intestines are visible.
(MP4)
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